Navigation Links
Many prostate cancer patients receive improper or 'mismatched' therapies
Date:11/25/2007

hat 389 patients reported pre-existing dysfunction, and more than one-third received mismatched treatments. Increasing clinical complexity of a patients condition had little effect on the likelihood of mismatched treatments. Patients who had a single baseline dysfunction that contraindicated one treatment were just as likely to be given a mismatched treatment as patients with weaker contraindications or patients for whom multiple treatments were contraindicated. As expected, mismatched brachytherapy and external beam radiation therapy led to worsened urinary and bowel symptoms, respectively.

The investigators plan to test whether incorporating prostate cancerspecific survey instruments into clinical practice may increase awareness of patient baseline dysfunction, reduce treatment mismatches, and improve outcomes.

The authors conclude that their observations raise concerns about physician-patient communication. Similar situations may also exist for other types of cancer, producing unsuspecting barriers to patient-centered choices of treatment, palliative care and hospice, say the authors.


'/>"/>

Contact: Amy Molnar
amolnar@wiley.com
Wiley-Blackwell
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Red wine compound shown to prevent prostate cancer
7. Barbershop Talks Cut Black Mens Prostate Cancer Risk
8. Generic prostate drug helps find high-risk cancers early
9. Finasteride unlikely to induce high grade prostate cancers
10. Shrinkage of prostate led to overestimation of cancer risk in trial
11. Prostate Cancer Awareness Week to Screen Thousands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... ... August 28, 2015 , ... The 6th Annual Survivor in the City, ... added yet another accolade to its cadre of widespread support—an official letter of support ... help of the medical community and the University of Illinois at Chicago’s Department of ...
(Date:8/28/2015)... ... August 28, 2015 , ... Saint Petersburg, FL —Pocket Protein™, ... fat, carbs, sugar, gluten, lactose or caffeine in a convenient 2 oz. pouch ... CPG Editor’s Choice Awards. , Five consumer packaged goods (CPG) products were selected ...
(Date:8/28/2015)... ... August 28, 2015 , ... Drugs and ... James Strawbridge, gives a new approach on solutions in his new book ":Unraveling ... employer and employees getting together for meaningful group meetings. "This would educate the ...
(Date:8/28/2015)... ... 28, 2015 , ... CARF International announced that West Ridge ... treatment and intensive family based services. , By pursuing and achieving accreditation, West ... of excellence. As a nonprofit charity for more than 50 years, West Ridge ...
(Date:8/28/2015)... Rochester, NY (PRWEB) , ... August 28, 2015 , ... ... injectable, Kybella™. It is the first and only nonsurgical product approved by the ... Dr. Vito Quatela and Dr. William Koenig are among ...
Breaking Medicine News(10 mins):Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 2Health News:Chicago Mayor Pens Official Support of Annual Survivor in the City Event Benefitting Brain Aneurysm Foundation 3Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 2Health News:Pocket Protein™ Named 2015 CPG Editor’s Choice Award Finalist by Informa’s SupplySide 3Health News:West Ridge Academy Awarded CARF Three-Year Accrediation 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 2Health News:Non-surgical Treatment to Get Rid of The "Double Chin," Kybella™, Now Available at the Quatela Center for Plastic Surgery 3
... News) -- A growing number of Americans are getting advice ... rather than friends, a new survey indicates. About ... media such as Facebook and Twitter, a substantial increase from ... who sought information from friends fell from 63 percent in ...
... Moffitt Cancer Center in Tampa, Fla., have discovered that ... roles in tobacco-related non-small cell lung cancers. Tobacco carcinogens ... The study was published in a recent issue ... identified oconogene, a gene linked to cancer," said study ...
... BOSTON (2-8-12) Observing that certain cancer cells may ... that this capability promotes rapid tumor growth. Now computer ... Muhammad Zaman and collaborators at the University of Texas ... model of healthy and cancer cells that they,ve created ...
... In a study to be presented today at the ... , in Dallas, Texas, researchers will report findings that ... section appear to know little about the risks and ... trial of labor to attempt a vaginal delivery, and ...
... TAMPA, Fla. and ORLANDO, Fla. Moffitt Cancer ... have announced they will collaborate on the creation ... Florida). The partnership will conduct collaborative research to ... areas of cancer and metabolic diseases, including obesity, ...
... supports an association between atypical fractures of the femur a ... and the use of bisphosphonates, drugs proven to enhance bone ... risk for suffering an atypical femur fracture while taking bisphosphonates ... after six years of treatment research presented today at ...
Cached Medicine News:Health News:More Patients Seek Plastic Surgery Advice From Facebook, Twitter 2Health News:Researchers find important 'target' playing role in tobacco-related lung cancers 2Health News:Boston University research suggests new pathways for cancer progression 2Health News:Study finds pregnant women with prior cesarean choose the delivery method preferred by their doctor 2Health News:Moffitt, Sanford-Burnham and Florida Hospital create Personalized Medicine Partnership of Florida 2Health News:Moffitt, Sanford-Burnham and Florida Hospital create Personalized Medicine Partnership of Florida 3Health News:Halting bone-building osteoporosis drug use cuts risk for additional atypical femur fracture in half 2
(Date:8/28/2015)... Aug. 28, 2015 Research ... of the "Investigation Report on China,s Ranibizumab Market, ... by Novartis, ranibizumab was approved by CFDA to treat ... only Lucentis, a product of Novartis, is available in ... first self- developed drug for the treatment of wet ...
(Date:8/28/2015)... 2015  IP Shakti, LLC, today announced that it has ... Logo - http://photos.prnewswire.com/prnh/20150827/261551LOGO ... corporate identity signifies our transformation into a company focused on ... for patent claim validity." ... AIA Shield™ platform, the Company commenced a corporate re-branding initiative ...
(Date:8/28/2015)...  Perrigo Company plc ("Perrigo") (NYSE: PRGO ; ... of leading OTC brands from GSK in an all ... a clear demonstration of Perrigo,s unique ability to maximize ... spanning 36 countries.  Perrigo Chairman, President ... are excited to complete this transaction, which clearly demonstrates ...
Breaking Medicine Technology:Investigation Report on China's Ranibizumab Market, 2012-2019 2IP Shakti, LLC Changes Company Name to Prediqtus, LLC 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 2Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 3Perrigo Completes Acquisition of Leading Portfolio of OTC Brands from GSK 4
... SILVER SPRING, Md., April 15, 2011 The U.S. ... given alone or in combination with methotrexate, for ... (SJIA) in children ages 2 years and older. ... SJIA, or Still,s disease, is a rare, potentially ...
... Inc., owner and operator of both Reptrax and VendorClear, ... leading vendor compliance solution. With the acquisition of Status ... industry,s credentialing efforts onto one standardized platform. Status Blue, ... care and grounded credentialing principles that are shared by ...
Cached Medicine Technology:FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis 2FDA Approves Actemra to Treat Rare Form of Juvenile Arthritis 3IntelliCentrics, Inc. Acquires Hospital Vendor Credentialing Solution Status Blue, LLC 2IntelliCentrics, Inc. Acquires Hospital Vendor Credentialing Solution Status Blue, LLC 3
Denman brown nucleus cracker with 30 angled shafts, tip to angle length 14.5 mm. Standard cross action handle. 1.1 mm x 1.2 mm paddle style tips....
Ernest nucleus cracker extra delicate cross-action serrated paddle shaped jaws for cracking the nucleus through a 2.5 mm incision....
Epilation forceps straight ends size 3.5"....
Removal Forceps, very fine pointed tips, with textured jaws, ideal for grasping wet sutures....
Medicine Products: